Company / Book Value per Share
Amphstar Pharmaceuticals, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$16.565
FY2025
5-year range
$9.38 / $16.565
FY2021-FY2025
Trend
+8.7%
vs FY2024
Sector context
#35 of 209
Health Care
What the data says
Amphstar Pharmaceuticals, Inc.'s book value per share of $16.565 is higher than 83% of companies in the Health Care sector (FY2025). Book Value per Share has increased for 7 consecutive years, from $7.13 in FY2018 to $16.565 in FY2025.
Based on SEC 10-K filings.
$16.565 in FY2025 with a 5-year CAGR of +13.9%. Top quartile in the Health Care sector.
Improved from $13.29 to $16.565 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +14.3%
- 5-Year CAGR
- +13.9%
- 10-Year CAGR
- -
Sector benchmark
-91.3% below sector average
Key checks
Key Insights
- Amphstar Pharmaceuticals, Inc.'s book value per share has grown for 7 consecutive years.
- 5-year CAGR of +13.9%, indicating consistent growth.
- In FY2025, book value per share increased 8.7% year-over-year.
- Ranks #35 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.565 | +8.7% |
| FY2024 | $15.234 | +14.6% |
| FY2023 | $13.29 | +20.0% |
| FY2022 | $11.08 | +18.1% |
| FY2021 | $9.38 | +8.6% |
| FY2020 | $8.637 | +5.6% |
| FY2019 | $8.178 | +14.7% |
| FY2018 | $7.13 | -1.2% |
| FY2017 | $7.216 | -0.9% |
| FY2016 | $7.285 | +10.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026